Publikationen von Tiago Fleming Outeiro
Alle Typen
Zeitschriftenartikel (129)
21.
Zeitschriftenartikel
168 (8), S. 1608 - 1624 (2024)
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry 22.
Zeitschriftenartikel
168 (8), S. 1514 - 1526 (2024)
Altered hippocampal doublecortin expression in Parkinson's disease. Journal of Neurochemistry 23.
Zeitschriftenartikel
168 (8), S. 1625 - 1639 (2024)
PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry 24.
Zeitschriftenartikel
14 (5), S. 917 - 924 (2024)
Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms. Journal of Parkinson's Disease 25.
Zeitschriftenartikel
23 (7), S. 669 (2024)
Abandon the NAC in α-synuclein. Lancet Neurology 26.
Zeitschriftenartikel
18, 1412450 (2024)
Age-related alterations in efferent medial olivocochlear-outer hair cell and primary auditory ribbon synapses in CBA/J mice. Frontiers in Cellular Neuroscience 27.
Zeitschriftenartikel
14 (4), S. 681 - 692 (2024)
Automated Capillary Electrophoresis Immunoblot for the Detection of Alpha-Synuclein in Mouse Tissue. Journal of Parkinson's Disease: JPD 28.
Zeitschriftenartikel
39 (6), S. 1080 - 1081 (2024)
Reply to: “Rethinking Parkinson's Disease: A Syndromic Perspective”. Movement Disorders 29.
Zeitschriftenartikel
39 (6), S. 929 - 933 (2024)
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice. Movement Disorders 30.
Zeitschriftenartikel
49, S. 1643 - 1654 (2024)
Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson’s Disease. Neurochemical Research 31.
Zeitschriftenartikel
122, 106078 (2024)
Towards a biological diagnosis of PD. Parkinsonism & Related Disorders 32.
Zeitschriftenartikel
23 (5), e14128 (2024)
Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1. Aging Cell 33.
Zeitschriftenartikel
39 (4), S. 321 - 328 (2024)
Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene. Neurología (English Edition) 34.
Zeitschriftenartikel
15 (4), 264 (2024)
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway. Cell Death and Disease 35.
Zeitschriftenartikel
31, S. 3797 - 3804 (2024)
Adsorption of alpha-synuclein and inhibition of fibril formation by nanocellulose and gold-coated-nanocellulose. Cellulose 36.
Zeitschriftenartikel
22, S. 2670 - 2676 (2024)
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments. Organic & Biomolecular Chemistry 37.
Zeitschriftenartikel
125 (3), e30523 (2024)
In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease. Journal of Cellular Biochemistry 38.
Zeitschriftenartikel
121 (2), e2309700120 (2024)
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid. PNAS 39.
Zeitschriftenartikel
13 (1), e6900 (2024)
Uncovering potential diagnostic and pathophysiological roles of α-synuclein and DJ-1 in melanoma. Cancer Medicine 40.
Zeitschriftenartikel
147 (1), S. 81 - 90 (2024)
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies. Brain